1.Isolation and pharmacodynamic characterization of the fibrinolytic fraction Ⅱ of Agkistrodon acutus venom
Jiashu CHEN ; Jiajun SUN ; Luguang LIANG
Chinese Pharmacological Bulletin 1987;0(01):-
By means of DEAE-sephadex A - 50 column chromatography, the venom of Agkistrodon acutus was separated into fifteen fractions. The fraction Ⅱ was rechro-matographed, on sephadex G - 50 column and a single peak was obtained. The polyacrylamide disc gel electrophoresis also showed a single band. The fraction Ⅱ had strong fibrinolytic activity on dog plasma fibrin plate and showed direct fibrinolytic effect on heated fibrin plate. In addition to fibrinolytic activity, the fraction Ⅱ had fibrinogenolytic activity, In vitro and at aconcentration less than 17. 8 mg?L-1,the potency of fibrinolysis was higher than that of fib-rinogenolysis. Local hemorrhage activity which is characteristic for crude venom of Agkistrodon a-cutus was not found when the fraction 1 was injected hyperdermically in rabbit. The ip LD50 value of the purified fraction Ⅱ was determined to be 11. 1 mg ? kg-1 in mice and there was no gross hemorrhage found in the dead animals.
2.Effects of chronic EECP on protein expression in thoracic aorta endothelial cells in porcine with hypercholesteremia
Xiaolin CHEN ; Xiaohong HE ; Yan ZHANG ; Yuetao QIAN ; Luguang LIANG ; Dianqiu FANG ; Dengyang ZHAN ; Zhensheng ZHENG ; Hong MA ; Kuijian WANG
Chinese Journal of Pathophysiology 2000;0(10):-
AIM: To explore the effect of chronic enhanced external counterpulsation(EECP) on the protein expression in thoracic aorta endothelial cells in porcine with hypercholesteremia by proteomic techniques.METHODS: After performed EECP for 36 h on the hypercholesteremia porcines,the endothelial cells(ECs) were collected from the thoracic aorta and analyzed with proteomic techniques.RESULTS: Six kinds of protein were detected in ECs in the EECP group,but not in the hypercholesteremia control group.CONCLUSION: Chronic EECP may protect ECs against damage resulted from hypercholesteremia by regulating protein expression in artery ECs,subsequently improving cell adhesion and intracellular lipid metabolism and reducing ECs apoptosis.